A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

Langford, CA; Cuthbertson, D; Ytterberg, SR; Khalidi, N; Monach, PA; Carette, S; Seo, P; Moreland, LW; Weisman, M; Koening, CL; Sreih, AG; Spiera, R; McAlear, CA; Warrington, KJ; Pagnoux, C; McKinnon, K; Forbess, LJ; Hoffman, GS; Borchin, R; Krischer

Langford, CA (reprint author), Cleveland Clin, Ctr Vasculitis Care & Res, 9500 Euclid Ave,A50, Cleveland, OH 44195 USA.

ARTHRITIS & RHEUMATOLOGY, 2017; 69 (4): 846

Abstract

Objective. To compare the efficacy of abatacept to that of placebo for the treatment of Takayasu arteritis (TAK). Methods. In this multicenter trial, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索